NBY - NovaBay Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

NovaBay Pharmaceuticals's activity chart (see below) currently has 18 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 20.83% of the time, taking 78.25 days on average.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 11-Nov-2024. First documented stock forecast 06-Feb-2017.

Best performing analysts who are covering NBY - NovaBay Pharmaceuticals:

Edward Woo Raghuram Selvaraju Scott Henry Jeffrey Cohen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Nov-2018

$0.85

2 years 11 days ago
(11-Nov-2024)

0/5 (0%)

$-1.5 (-63.83%)

Buy Since 18-Sep-2019

$13475

2 years 6 months 9 days ago
(13-May-2024)

0/3 (0%)

$11167.22 (483.89%)

Buy Since 06-Feb-2017

$7656.27

$24500

7 years 8 months 9 days ago
(13-Mar-2019)

1/3 (33.33%)

$2109.51 (38.03%)

89

Buy Since 05-Jun-2017

$4900

$33687.57

8 years 7 months 27 days ago
(26-Mar-2018)

1/2 (50%)

$-9472.99 (-65.91%)

224

Show more analysts

Please expand the browser size to see the chart

What is NBY (NovaBay Pharmaceuticals) average time for price targets to be met?

On average it took 78 days for the stock forecasts to be reached, with an average price target met ratio of 20.83%.

Which analyst most recently updated their price target on NBY (NovaBay Pharmaceuticals)?

Edward Woo

Which analyst has the lowest performance score on NBY (NovaBay Pharmaceuticals) with a proven track record?

JEFFREY COHEN

Which analyst has the most public recommendations on NBY (NovaBay Pharmaceuticals)?

Edward Woo works at ASCENDIANT and has 5 price targets and 5 ratings on NBY

Which analyst is the currently most bullish on NBY (NovaBay Pharmaceuticals)?

Raghuram Selvaraju with the highest potential upside of $7655.06

Which analyst is the currently most reserved on NBY (NovaBay Pharmaceuticals)?

Edward Woo with the lowest potential downside of -$0.36
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?